Tranexamic Acid Tablet bulk supplier for pharma manufacturers

Tranexamic Acid Tablet 500 mg, 650 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500 mg, 650 mg

Reference Brands: Lysteda®(US)

Tranexamic Acid, an antifibrinolytic, prevents excessive bleeding in surgeries and trauma. Available in 500 mg tablets and 100 mg/mL IV injections, it’s marketed as Cyklokapron®, Lysteda®, and Exacyl®. Pharma B2B platforms offer global buyers compliant, bulk sourcing of tranexamic acid from trusted, GMP-certified manufacturers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Tranexamic Acid is an antifibrinolytic agent used to reduce or prevent excessive bleeding in surgical, trauma, and gynecological settings. Available in IV and oral forms, it is commonly supplied as 100 mg/mL injection or 500 mg tablets. Leading brands include Cyklokapron® (Pfizer), Lysteda® (Ferring), and Exacyl® (Sanofi). Widely adopted in both emergency medicine and elective surgeries, tranexamic acid helps stabilize clots and minimize transfusion needs. Pharma B2B platforms provide access to GMP-certified tranexamic acid products in bulk quantities, supporting hospitals, surgical centers, and emergency care providers with reliable global sourcing and compliance with US and EU pharmaceutical standards.

Tranexamic Acid Tablet — third party manufacturing & bulk supply

Tranexamic Acid Tablet 500 mg, 650 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tranexamic Acid Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tranexamic Acid Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tranexamic Acid Tablet →

Back to Listing

Frequently Asked Questions

Tranexamic Acid Tablet is used to prevent and control excessive bleeding in conditions such as heavy menstrual bleeding (menorrhagia), nosebleeds, dental procedures, and surgeries. It works by preventing the breakdown of blood clots, thereby reducing blood loss.

Tranexamic Acid Tablet is made from the active pharmaceutical ingredient Tranexamic Acid, a synthetic derivative of the amino acid lysine that helps stabilize blood clots.

The common trade names of Tranexamic Acid Tablet include Lysteda, Cyklokapron, Pause, Trapic, Texakind, Tranlok, and Transamin.

Tranexamic Acid Tablets are manufactured by multiple pharmaceutical companies worldwide. Lysteda is marketed by Ferring Pharmaceuticals in the USA, while many Indian and global manufacturers produce generic versions.

The generic name of Tranexamic Acid Tablet is Tranexamic Acid.

The brand names of Tranexamic Acid Tablet include Lysteda, Cyklokapron, Pause, Trapic, Texakind, Tranlok, and Transamin.

Tranexamic Acid Tablets are manufactured in multiple countries including the USA, Europe, India, and other global pharmaceutical manufacturing hubs depending on the manufacturer.